Saturday , June 23 2018

From the Editor

June, 2018

  • 23 June

    June 23, 2018

    The ADA Scientific sessions are underway in Orlando and Steve Freed and Joy Pape, along with our two interns Kaytie and Kennen, and guest Michele Laine, ARNP, CDE, are there to cover all the latest in diabetes, and interview the thought leaders on where diabetes care is and where it …

    Read More »

Latest Articles

June, 2018

Test Your Knowledge

Test Your Knowledge: Clinical Case Vignette: Smoking and Type 2

You are concerned about Mr. Carlson’s cigarette use because cigarette smoking has been shown to have multiple physiological impacts on health. Which one of the following statements regarding smoking and type 2 diabetes is true?

Correct

Answer: B. In individuals with diabetes, it causes more rapid progression to micro- and macroalbuminuria

Educational Critique: Smoking cessation support for patients with diabetes is important and should be given high priority. In patients with diabetes, smoking is an independent risk factor for developing macrovascular and microvascular complications. In addition to being an independent risk factor, smoking causes more rapid progression to micro- and macroalbuminuria. Overall mortality is higher in people who smoke and who have diabetes when compared to the patient who do not smoke nor have diabetes. Studies suggest that smoking may induce diabetes and smoking has been shown to worsen glycemic control and insulin resistance. There are a variety of medications that can be used to help patients with diabetes to stop smoking. Bupropion is one of them.

Incorrect

More Articles

June, 2018

  • 23 June

    Being Overweight in Childhood Increases Risk of Diabetes in Adulthood?

    Childhood overweight is associated with an increased risk of type 2 diabetes in adulthood.

    Read More »
  • 23 June

    Combo Treatment to Reach Goal

    Would you feel comfortable using a combination treatment of a GLP-1 receptor agonist and a SGLT-2 inhibitor for a patient who has not reached goal? Follow the link to respond.

    Read More »
  • 19 June

    Don’t Stop: Encouraging Patient Success

    When prescribed lifestyle changes and or medication(s), patients who have diabetes, obesity, hypertension, or any chronic condition that is easy to monitor, even from home, may agree to these changes at first. They can almost immediately get improvements in their numbers. It can be encouraging. For some, seeing those numbers change for the better encourages them to keep on keeping on. However, others may think they are healed and stop treatment. Their numbers may go back to the same or even "worse" than before the treatment.

    Read More »
  • 19 June

    Jeffrey Mechanick 2018 Complete Interview

    Diabetes in Control speaks with top endocrinologists and other medical professionals to bring you the latest in diabetes news and research. This week, we have another exclusive interview from the AACE 2018  in Boston, MA. Dr. Jeffrey Mechanick, MD, FACE, FACR, FACN, ECNU is Professor of Medicine and Medical Director …

    Read More »
  • 19 June

    Future Use of Technology in Outpatient Care Part 3

    In this week's Homerun Slides, asking the question of how to translate knowledge and implications of pathophysiology, progression, and diabetes complications to the prevention, early diagnosis and optimal treatment of diabetes and its complications.

    Read More »
  • 19 June

    International Textbook of Diabetes Mellitus, 4th Ed., Excerpt #130: Pathogenesis of Type 2 Diabetes Mellitus Part 1

    Normal glucose homeostasis: Any discussion of the pathogenesis of type 2 diabetes mellitus (T2DM) must start with a review of mechanisms involved in the maintenance of normal glucose homeostasis in the basal o postabsorptive state (10–12-h overnight fast) and following ingestion of a typical mixed meal. In the postabsorptive state the great majority of total body glucose disposal takes place in insulin independent tissues.

    Read More »
  • 19 June

    Jeffrey Mechanick 2018 Transcript

    In this exclusive interview transcript, Dr. Jeffrey Mechanick discusses transcultural endocrinology and the different ways diabetes care can be fashioned based on different cultures and ethnicities.

    Read More »
  • 19 June

    Jeffrey Mechanick Full Interview

    In this Exclusive Interview, Dr. Jeffrey Mechanick talks with Diabetes in Control Publisher Steve Freed during the AACE 2018 convention in Boston, MA about transcultural endocrinology and gives a summary of recent activities for a program focused on diabetes care across America.

    Read More »
  • 19 June

    Jeffrey Mechanick Part 1, Introduction Trans-Cultural Endocrinology

    In part 1 of this Exclusive Interview, Dr. Jeffrey Mechanick talks with Diabetes in Control Publisher Steve Freed during the AACE 2018 convention in Boston, MA about the concept of trans-cultural endocrinology and why it is essential to understand how differences in culture can impact diabetes care.

    Read More »
  • 19 June

    Jeffrey Mechanick Part 2, Trans-Cultural Endocrinology in America

    In part 2 of this Exclusive Interview, Dr. Jeffrey Mechanick talks with Diabetes in Control Publisher Steve Freed during the AACE 2018 convention in Boston, MA about trans-cultural endocrinology in America and how doctors can take patient culture into account when planning individualized care.

    Read More »